×
About 2,608 results

ALLMedicine™ Polymyositis Center

Research & Reviews  740 results

Pain profile and opioid medication use in patients with idiopathic inflammatory myopath...
https://doi.org/10.1093/rheumatology/keac271
Rheumatology (Oxford, England); Bhashyam A, Lubinus M et. al.

May 18th, 2022 - Pain is commonly reported in people living with myositis. This study assesses the presence of pain in the subtypes of myositis as well frequency of opioid and non-opioid pain medication use. A survey was developed and distributed by Myositis Suppo...

Polymyositis as a paraneoplastic syndrome of a patient with primary pulmonary lymphoepi...
https://doi.org/10.1186/s13019-022-01860-4 10.5858/arpa.2018-0149-RS 10.1053/hupa.2001.26457 10.1097/00000478-200206000-00004 10.1097/RTI.0000000000000070 10.1007/s00330-002-1535-7 10.1309/148K-ND54-6NJX-NA61 10.1016/S0140-6736(03)14368-1 10.1016/S0140-6736(00)03540-6 10.1007/s002960000070 10.1080/14397595.2018.1467257 10.2169/internalmedicine.4702-20 10.1111/j.1440-1843.2006.00910.x 10.1016/j.rpor.2019.09.010 10.1016/j.eucr.2015.12.006 10.2147/OTT.S234945 10.1002/jso.2930360413 10.1309/BUAN-BGFW-69U9-C3H8 10.1097/JTO.0000000000000630 10.1111/j.1365-2559.1996.tb01414.x 10.3892/ol.2017.6510 10.1016/j.ejrad.2013.02.006 10.1016/j.diii.2016.06.020 10.1097/MNM.0000000000000475 10.1002/cncr.27452 10.1196/annals.1318.041 10.1007/s11864-017-0494-9 10.1016/j.cllc.2012.01.002 10.1007/s10147-021-01921-z 10.1002/cncr.24181 10.1016/j.lungcan.2015.03.017 10.1016/j.prp.2020.153043 10.2147/OTT.S290113 10.7326/0003-4819-122-9-199505010-00010 10.1007/s12016-015-8510-y 10.1515/cclm-2018-0928 10.1136/annrheumdis-2017-211468 10.1007/s10067-015-3065-0 10.1093/rheumatology/kev192 10.31768/2312-8852.2018.40(3):239-242 10.1371/journal.pone.0181564 10.1016/j.lungcan.2008.05.006
Journal of Cardiothoracic Surgery; Lei Y, Liu C et. al.

May 18th, 2022 - Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare type of non-small cell lung cancer, which mostly occurred in non-smoking Asian populations. The prognosis of this tumor is better than other lung cancers. Polymyositis, a kind of idiopath...

Ciguatera Toxicity
https://emedicine.medscape.com/article/813869-overview

May 14th, 2022 - Practice Essentials Ciguatera poisoning is the most common nonbacterial fish-borne poisoning in the United States. [1] It is caused by consumption of reef fish contaminated with ciguatoxin, which originates with certain dinoflagellates (ie, algae)...

Ciguatera Toxicity Clinical Presentation
http://emedicine.medscape.com/article/813869-clinical

May 14th, 2022 - History Currently, ciguatera poisoning is a clinical diagnosis based upon a constellation of symptoms temporally related to ingestion of suspect fish products. Multiple individuals consuming the same fish and experiencing signs and symptoms consis...

Hypothyroid Myopathy
https://emedicine.medscape.com/article/313915-print

May 9th, 2022 - Practice Essentials Deficiency of thyroid hormone leads to a state called hypothyroidism. Common causes of hypothyroidism include the following: Treatment with radioactive iodine (I 131) for Graves disease Hashimoto disease - An autoimmune process...

see more →

Guidelines  2 results

Treatment consensus for management of polymyositis and dermatomyositis among rheumatolo...
https://doi.org/10.1111/1346-8138.14604
The Journal of Dermatology; Kohsaka H, Mimori T et. al.

Dec 19th, 2018 - Although rheumatologists, neurologists and dermatologists see patients with polymyositis (PM) and dermatomyositis (DM), their management appears to vary depending on the physician's specialty. The aim of the present study was to establish the trea...

2016 American College of Rheumatology/European League Against Rheumatism criteria for m...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496443
Annals of the Rheumatic Diseases; Aggarwal R, Rider LG et. al.

Apr 8th, 2017 - To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Expert surveys, logistic regression, and conjoint analysis were used to develop 287 definitions using core set measures. Myositis experts rated greater improvement ...

see more →

Drugs  229 results see all →

Clinicaltrials.gov  11 results

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis
https://clinicaltrials.gov/ct2/show/NCT04976140

May 2nd, 2022 - This Phase 1/2a clinical trial involves patients diagnosed with refractory polymyositis or dermatomyositis. The initial safety assessment is conducted, including development of DLT in subjects up to Week 2 after the investigational product adminis...

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
https://clinicaltrials.gov/ct2/show/NCT04628936

Dec 9th, 2021 - This is an open-label study to evaluate the long-term efficacy and safety of KZR-616 in patients with active polymyositis or dermatomyositis who completed the double-blind treatment period of Study KZR-616-003, up to and including the Week 32 Visi...

Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
https://clinicaltrials.gov/ct2/show/NCT01862926

Oct 7th, 2021 - Interstitial lung disease (ILD) is characterised by inflammation and scarring of the lung and is the leading cause of death in patients with systemic sclerosis, and contributes significantly to morbidity and mortality in many other connective tiss...

A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
https://clinicaltrials.gov/ct2/show/NCT02780674

Dec 21st, 2018 - MEDI7734 is a human monoclonal antibody that binds to and causes temporary depletion of plasmacytoid dendritic cells (pDCs), a type of white blood cell. The objectives of this study are to evaluate the safety, drug levels, and pDC levels in subjec...

Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis
https://clinicaltrials.gov/ct2/show/NCT03324152

Apr 23rd, 2018 - Patients randomized to the HIIT protocol will train three days a week for 12 weeks. Before exercise start participants will rate self-reported pain and fatigue on a visual analogue scale and describe in own words information about possible changes...

see more →

News  57 results

Fast Five Quiz: Progressive Fibrosing Interstitial Lung Disease
https://www.medscape.com/viewarticle/969959

Apr 12th, 2022 - Interstitial lung diseases (ILDs) encompass a large and varied group of parenchymal lung disorders, including diseases of unknown cause, which are known as idiopathic interstitial pneumonias, as well as those associated with other diseases or envi...

Predicting Treatment Response in Inflammatory Muscle Disorders
https://www.medpagetoday.com/rheumatology/generalrheumatology/97219

Feb 16th, 2022 - Rheumatologists looking for clues to whether their patients with certain inflammatory myopathies will improve on immunosuppressive drugs may find them in a new study appearing in Arthritis Care & Research. Presence of dermatomyositis-specific auto...

Polymyositis-Dermatomyositis Tied to Arrhythmias in Young, Middle-Aged Adults
https://www.medscape.com/viewarticle/953329

Jun 18th, 2021 - (Reuters Health) - Young and middle-aged adults with polymyositis-dermatomyositis are more likely to have arrhythmias in general, and supraventricular arrhythmias in particular, than matched controls without these rare rheumatic conditions, a U.S....

Consider Home Subcutaneous Immune Globulin for Refractory Dermatomyositis
https://www.medscape.com/viewarticle/946138

Feb 19th, 2021 - Home-based subcutaneous immune globulin therapy is a promising alternative to intravenous immune globulin therapy for patients with refractory dermatomyositis or polymyositis, Anna Postolova, MD, MPH, declared at the 2021 Rheumatology Winter Clini...

Role of Aspirin Explored in Primary Prevention of CVD in Systemic Rheumatic Diseases
https://www.medscape.com/viewarticle/937809

Sep 22nd, 2020 - Low-dose aspirin may be considered for the primary prevention of cardiovascular disease (CVD) in patients with autoimmune systemic rheumatic diseases who are at particularly high risk because of their individual cardiovascular risk profile, accord...

see more →

Patient Education  4 results see all →